Xudong kong

Shanghai Jiao Tong University, Shanghai, Shanghai Shi, China 
Phage display, cyclic peptide, protein evolution
"Xudong kong"
Mean distance: (not calculated yet)
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Carle V, Kong XD, Comberlato A, et al. (2021) Generation of a 100-billion cyclic peptide phage display library having a high skeletal diversity. Protein Engineering, Design & Selection : Peds. 34
Kong XD, Heinis C. (2021) Towards the Development of Orally Available Peptide Therapeutics. Chimia. 75: 514-517
Stevens CA, Bachtiger F, Kong XD, et al. (2021) A minimalistic cyclic ice-binding peptide from phage display. Nature Communications. 12: 2675
Carle V, Wu Y, Mukherjee R, et al. (2021) Development of Selective FXIa Inhibitors Based on Cyclic Peptides and Their Application for Safe Anticoagulation. Journal of Medicinal Chemistry
Kong XD, Carle V, Díaz-Perlas C, et al. (2020) Generation of a Large Peptide Phage Display Library by Self-Ligation of Whole-Plasmid PCR Product. Acs Chemical Biology
Wilbs J, Kong XD, Middendorp SJ, et al. (2020) Cyclic peptide FXII inhibitor provides safe anticoagulation in a thrombosis model and in artificial lungs. Nature Communications. 11: 3890
Kong X, Moriya J, Carle V, et al. (2020) De novo development of proteolytically resistant therapeutic peptides for oral administration Nature Biomedical Engineering. 4: 560-571
Maola K, Wilbs J, Touati J, et al. (2019) Engineered Peptide Macrocycles Can Inhibit Matrix Metalloproteinases with High Selectivity Angewandte Chemie. 58: 11801-11805
Kale SS, Villequey C, Kong XD, et al. (2018) Cyclization of peptides with two chemical bridges affords large scaffold diversities. Nature Chemistry
Villequey C, Kong XD, Heinis C. (2017) Bypassing bacterial infection in phage display by sequencing DNA released from phage particles. Protein Engineering, Design & Selection : Peds. 30: 761-768
See more...